Literature DB >> 17536725

Chemical fingerprint and quantitative analysis of fructus psoraleae by high-performance liquid chromatography.

Chun-Feng Qiao1, Quan-Bin Han, Jing-Zheng Song, Shi-Fu Mo, Ling-Dong Kong, Hsiang-Fu Kung, Hong-Xi Xu.   

Abstract

Fructus Psoraleae, a widely used traditional Chinese medicine, is well known as a health supplement ingredient. In our study, an improved and comprehensive HPLC fingerprint of Fructus Psoraleae was established. Two important new benzofuran glycosides, psoralenoside and isopsoralenoside, were identified as characteristic constituents for the first time. HPLC separation was performed on an RP-C8 column. The mobile phase was acetonitrile and 0.1% acetic acid solution with linear gradient change of acetonitrile from 10 to 82% in 40 min. The flow rate was 1.0 mL/min, and the detection wavelength was set at 310 nm. The HPLC chromatograms of twenty-six samples from different regions of China showed a similar pattern. Twelve peaks were selected as characteristic peaks and further identified as psoralenoside, isopsoralenoside, psoralen, isopsoralen, bavachromene, corylifolin, corylin, psoralidin, isobavachalcone, bavachinin, corylifol A, and bakuchiol, respectively. Nine of them were simultaneously quantitatively analyzed for the first time. A more comprehensive analytical method was established for the fingerprint of Fructus Psoraleae. It is very useful for authentication and quality assessment of the crude drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536725     DOI: 10.1002/jssc.200600339

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.614


  14 in total

Review 1.  Isobavachalcone: an overview.

Authors:  Victor Kuete; Louis P Sandjo
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

2.  Chemical fingerprinting and quantitative analysis of a Panax notoginseng preparation using HPLC-UV and HPLC-MS.

Authors:  Hong Yao; Peiying Shi; Qing Shao; Xiaohui Fan
Journal:  Chin Med       Date:  2011-02-24       Impact factor: 5.455

3.  Psoralea corylifolia Linn.-"Kushtanashini".

Authors:  P S Khushboo; V M Jadhav; V J Kadam; N S Sathe
Journal:  Pharmacogn Rev       Date:  2010-01

4.  Fingerprint analysis of processed Rhizoma Chuanxiong by high-performance liquid chromatography coupled with diode array detection.

Authors:  Jia-Yan Fang; Lin Zhu; Tao Yi; Jian-Ye Zhang; Ling Yi; Zhi-Tao Liang; Li Xia; Jia-Fu Feng; Jun Xu; Yi-Na Tang; Zhong-Zhen Zhao; Hu-Biao Chen
Journal:  Chin Med       Date:  2015-02-10       Impact factor: 5.455

5.  Glycyrrhetinic acid might increase the nephrotoxicity of bakuchiol by inhibiting cytochrome P450 isoenzymes.

Authors:  Aifang Li; Nana Ma; Zijing Zhao; Mei Yuan; Hua Li; Qi Wang
Journal:  PeerJ       Date:  2016-11-22       Impact factor: 2.984

6.  Chiral separation of bavachinin in Fructus Psoraleae and rat plasma by liquid chromatography using permethylated-β-CD as a chiral selector.

Authors:  Jing-Jing Liu; Juan Zhang; Zi-Lin Chen
Journal:  J Pharm Anal       Date:  2013-01-23

7.  Simultaneous quantification of five major active components in capsules of the traditional Chinese medicine 'Shu-Jin-Zhi-Tong' by high performance liquid chromatography.

Authors:  Xing-Xin Yang; Xiao-Xia Zhang; Rui-Miao Chang; Yan-Wei Wang; Xiao-Ni Li
Journal:  J Pharm Anal       Date:  2011-10-22

8.  Insecticidal and genotoxic activity of Psoralea corylifolia Linn. (Fabaceae) against Culex quinquefasciatus Say, 1823.

Authors:  Virendra K Dua; Arvind Kumar; Akhilesh C Pandey; Sandeep Kumar
Journal:  Parasit Vectors       Date:  2013-02-04       Impact factor: 3.876

9.  Diverse role of fast growing rhizobia in growth promotion and enhancement of psoralen content in Psoralea corylifolia L.

Authors:  Chandra Prabha; D K Maheshwari; Vivek K Bajpai
Journal:  Pharmacogn Mag       Date:  2013-10       Impact factor: 1.085

10.  Comparison of the Inhibitory Potential of Bavachalcone and Corylin against UDP-Glucuronosyltransferases.

Authors:  Lina Shan; Shuman Yang; Gang Zhang; Dun Zhou; Zhenyu Qiu; Lei Tian; Hongxia Yuan; Yujun Feng; Xianbao Shi
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.